99mTc-/Re-labeled prostate specific membrane antigen inhibitors (Progenics Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name99mTc-/Re-labeled prostate specific membrane antigen inhibitors (Progenics Pharmaceuticals)
Drug Alias Name99mTc-/Re-labeled prostate specific membrane antigen inhibitors (Molecular Insight Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Insight Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Insight Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A